Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02311322 · ClinicalTrials.gov registry record

Genetic Causes of Growth Disorders

A clinical trial, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Terminated
Registry status
334
Enrollment target

NCT02311322 is a clinical trial that was terminated before completion, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 334 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02311322 was terminated before completion, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

TERMINATED
Registry status
334 participants
Enrollment target

Study Summary

Background: \- Some growth disorders are caused by a change in genes. Genes are the instructions the body uses to function. Changes in genes often cause them not to work correctly. Researchers want to use a new technology called exome sequencing, to look at many genes at once. This is done by looking at DNA from blood or saliva in a lab. This method may help find the cause of disorders that researchers haven t been able to find using past methods. Objectives: \- To better understand genetic causes of growth disorders. Eligibility: \- Children and adults with growth disorders and their family members. Design: * Participants will give a small sample of blood and/or saliva. * Researchers will purify DNA from the sample. They will perform exome sequencing and other tests to look for changes in genes. Some participants may receive limited or no genetic tests. Researchers will let them know if exome sequencing is performed. * Participants may have a medical history, physical exam, and lab tests. They may have x-rays or ultrasound tests to study the disorder in their family. * Some participants may be recommended for a specific genetic test from a commercial lab. They may have to pay for that test. * Participants will be told about test results that relate to the growth disorder. This may happen up to years after the testing. They may have to give another blood and/or saliva sample. * Some participants may get results about other health conditions. This will only happen if the information would help the person or their family protect their health. They may have to give another blood and/or saliva sample.

Trial Details

FieldValue
Enrollment Target 334 participants
Start Date 2014-12-02
Est. Completion 2023-03-14

What the Registry Record Tells You About NCT02311322

The ClinicalTrials.gov registry entry for NCT02311322 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 334 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02311322 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02311322 about?

NCT02311322 is a clinical study titled "Genetic Causes of Growth Disorders". Background: \- Some growth disorders are caused by a change in genes. Genes are the instructions the body uses to function. Changes in genes often cause them not to work correctly. Researchers want to use a new technology called exome sequencing, to look at many genes at once. This is done by looki...

What is the current status of trial NCT02311322?

This trial is currently terminated. The enrollment target is 334 participants. The study started on 2014-12-02. Estimated completion is 2023-03-14.

Who is sponsoring clinical trial NCT02311322?

This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.